BioCentury
ARTICLE | Company News

Halozyme management update

April 7, 2014 7:00 AM UTC

Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine/Metabolic, Cancer, Dermatology Resigned: James Shaffer as VP and chief commercial officer ...